Skip to content

Teva Pharmaceutical Industries

US · TEVA #471 by market cap Listed 1970
39.23 +0.69 +1.79%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 13 analysts

Buy
Avg price target 51.54 +31.4%
Price target rangecurrent 39.23
Low45.94
Avg51.54
High57.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-19 Leerink Partners -- Buy --
2026-11-18 Barclays -- Buy 50.00
2026-11-17 H.C. Wainwright -- Buy 54.00
2026-11-16 Argus Research -- Buy 50.00
2026-11-12 TD Cowen -- Buy 57.00
2026-11-12 Piper Sandler -- Buy 56.00
2026-11-12 Evercore -- Buy --
2026-11-12 H.C. Wainwright -- Buy 54.00
2026-11-12 Oppenheimer -- Buy 54.00
2026-11-11 BofA Securities -- Buy 48.00
2026-11-04 Scotiabank -- Buy 47.00
2026-11-04 Goldman Sachs -- Buy 55.00
2026-11-04 H.C. Wainwright -- Buy 54.00
2026-11-04 J.P. Morgan -- Buy 50.00
2026-11-03 BofA Securities -- Buy 48.00
2026-11-03 Scotiabank -- Buy 47.00
2026-11-02 H.C. Wainwright -- Buy 52.00
2026-10-23 Piper Sandler -- Buy 44.00
2026-10-15 Barclays -- Buy 47.00
2026-10-12 Scotiabank -- Buy 47.00
2026-10-12 Leader Capital Markets -- Buy 45.94
2026-10-12 Goldman Sachs -- Buy 50.00
2026-10-12 Barclays -- Buy 42.00
2026-10-11 J.P. Morgan -- Buy 50.00
2026-10-09 BofA Securities -- Buy 43.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 -- ±6.58% +2.97% (in line)
2026/Q2 2026-07-29 -- ±6.19% +9.60% (beat)
2026/Q1 2026-04-29 -- ±12.22% +11.89% (in line)
2025/Q4 2026-01-28 -- ±6.43% +2.09% (in line)
2025/Q3 2025-11-05 -- ±6.14% +20.23% (beat)
2025/Q2 2025-07-30 -- ±8.15% +1.75% (in line)
2025/Q1 2025-05-07 -- ±9.79% +9.18% (in line)
2024/Q4 2025-01-29 -- ±7.94% -13.89% (beat)
2024/Q3 2024-11-06 -- ±7.99% -7.14% (in line)
2024/Q2 2024-07-31 -- ±10.41% +6.22% (in line)
2024/Q1 2024-05-08 -- ±7.44% +12.83% (beat)
2023/Q4 2024-01-31 -- ±9.30% +3.15% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:01:26 · For reference only, not investment advice and not tailored to your situation.

Teva Pharmaceutical Industries discussion 0 comments

Add a comment